Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response Publisher Pubmed



Kheshti AMS1 ; Hajizadeh F2 ; Barshidi A1 ; Rashidi B1 ; Ebrahimi F3 ; Bahmanpour S1 ; Karpisheh V1 ; Noukabadi FK4 ; Kiani FK1 ; Hassannia H5 ; Atyabi F6 ; Kiaie SH1, 7 ; Kashanchi F8 ; Navashenaq JG9 Show All Authors
Authors
  1. Kheshti AMS1
  2. Hajizadeh F2
  3. Barshidi A1
  4. Rashidi B1
  5. Ebrahimi F3
  6. Bahmanpour S1
  7. Karpisheh V1
  8. Noukabadi FK4
  9. Kiani FK1
  10. Hassannia H5
  11. Atyabi F6
  12. Kiaie SH1, 7
  13. Kashanchi F8
  14. Navashenaq JG9
  15. Mohammadi H10
  16. Bagherifar R7
  17. Jafari R11, 12
  18. Zolbanin NM12, 13, 14
  19. Jadidiniaragh F1, 15, 16

Source: Pharmaceutical Research Published:2022


Abstract

Purpose: The invention and application of new immunotherapeutic methods can compensate for the inefficiency of conventional cancer treatment approaches, partly due to the inhibitory microenvironment of the tumor. In this study, we tried to inhibit the growth of cancer cells and induce anti-tumor immune responses by silencing the expression of the β-catenin in the tumor microenvironment and transmitting interleukin (IL)-15 cytokine to provide optimal conditions for the dendritic cell (DC) vaccine. Methods: For this purpose, we used folic acid (FA)-conjugated SPION-carboxymethyl dextran (CMD) chitosan (C) nanoparticles (NPs) to deliver anti-β-catenin siRNA and IL-15 to cancer cells. Results: The results showed that the codelivery of β-catenin siRNA and IL-15 significantly reduced the growth of cancer cells and increased the immune response. The treatment also considerably stimulated the performance of the DC vaccine in triggering anti-tumor immunity, which inhibited tumor development and increased survival in mice in two different cancer models. Conclusions: These findings suggest that the use of new nanocarriers such as SPION-C-CMD-FA could be an effective way to use as a novel combination therapy consisting of β-catenin siRNA, IL-15, and DC vaccine to treat cancer. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
6. Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)
19. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
20. Tumor Immunology, Clinical Immunology (2022)